Sort
10,766 grants matching “checkpoint inhibitor”
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$369,912Drew M. Pardoll · Johns Hopkins University · R01 · FY2020 · CA
Regulation of the Development of Trypanosoma brucei
$369,849Ching Chung Wang · University Of California, San Francisco · R01 · FY2006 · AI
Project 3: Localized microneedle-directed combination immunotherapy for cSCC
$369,675Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
Control of Cell Fate and Proliferation in the Developing Eye
$369,674Utpal Banerjee · University Of California Los Angeles · R01 · FY2008 · EY
B55 alpha deficiency as a therapeutic target in cancer
$369,660Junran Zhang · Ohio State University · R01 · FY2020 · CA
Imaging tumor associated macrophage (TAM) function
$369,444Ralph Weissleder · Massachusetts General Hospital · R01 · FY2019 · CA
The Role of ZEB1 in promoting therapeutic resistance through its interaction with 53BP1Â
$369,431James M Larner · University Of Virginia · R01 · FY2022 · CA
The Role of ZEB1 in promoting therapeutic resistance through its interaction with 53BP1Â
$369,431James M Larner · University Of Virginia · R01 · FY2025 · CA
Identification of genetic interactors of Brca2
$369,367Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapy
$369,354Elad Ziv · University Of California, San Francisco · P20 · FY2024 · CA
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$369,337Tracy L McGaha · University Health Network · R01 · FY2022 · CA
Regulation of p53 by TAF1
$369,313Xuan Liu · University Of California Riverside · R01 · FY2020 · CA
Bile acids restrict functional reprogramming of myeloid-derived suppressor cells in tumor beds
$369,216Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Characterizing oncogenic function of ITCH in melanoma
$369,216Lixin Wan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Characterizing oncogenic function of ITCH in melanoma
$369,216Lixin Wan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Bile acids restrict functional reprogramming of myeloid-derived suppressor cells in tumor beds
$369,216Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
RP-3: Elucidating Mechanisms of Sensitivity and Resistance to Checkpoint Blockade Therapy for Rational Multi-Drug Immunotherapy in Urothelial Cancers
$369,155Timothy An-Thy Chan · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA
DEREGULATION OF CELLULAR IKB KINASES BY HTLV1 TAX
$369,072Vanderbilt University · R01 · FY2001 · CA
Core 1: Biospecimen and Data Management Core
$369,028John B Sunwoo · Stanford University · U54 · FY2017 · CA
Core C: Patient Derived Xenograft (PDX)/ Syngeneic Mouse Core
$369,017Gatien Moriceau · University Of California Los Angeles · P01 · FY2024 · CA
Impact of Host NF-kB Signaling in Radiation Therapy
$368,926Shigeki Miyamoto · University Of Wisconsin-Madison · R01 · FY2023 · CA
Impact of Host NF-kB Signaling in Radiation Therapy
$368,926Shigeki Miyamoto · University Of Wisconsin-Madison · R01 · FY2022 · CA
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers
$368,899Jinming Gao · Ut Southwestern Medical Center · R01 · FY2022 · CA
Regulation of p53 by TAF1
$368,818Xuan Liu · University Of California Riverside · R01 · FY2018 · CA
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
$368,805Guang Peng · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA